Northern Trust Corp increased its stake in shares of PetMed Express, Inc. (NASDAQ:PETS) by 2.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 287,838 shares of the company’s stock after acquiring an additional 7,549 shares during the quarter. Northern Trust Corp owned about 1.42% of PetMed Express worth $11,686,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the stock. Pinebridge Investments L.P. boosted its position in shares of PetMed Express by 1.0% during the second quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock worth $110,000 after acquiring an additional 27 shares during the last quarter. Arizona State Retirement System boosted its position in shares of PetMed Express by 0.9% during the first quarter. Arizona State Retirement System now owns 10,667 shares of the company’s stock worth $215,000 after acquiring an additional 100 shares during the last quarter. Texas Permanent School Fund boosted its position in shares of PetMed Express by 0.8% during the second quarter. Texas Permanent School Fund now owns 14,986 shares of the company’s stock worth $608,000 after acquiring an additional 125 shares during the last quarter. Thrivent Financial For Lutherans raised its stake in PetMed Express by 4.1% during the first quarter. Thrivent Financial For Lutherans now owns 11,530 shares of the company’s stock valued at $232,000 after purchasing an additional 450 shares in the last quarter. Finally, Teachers Advisors LLC raised its stake in PetMed Express by 1.8% during the first quarter. Teachers Advisors LLC now owns 61,884 shares of the company’s stock valued at $1,246,000 after purchasing an additional 1,097 shares in the last quarter. Hedge funds and other institutional investors own 87.13% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “PetMed Express, Inc. (NASDAQ:PETS) Position Lifted by Northern Trust Corp” was first published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://www.truebluetribune.com/2017/11/14/northern-trust-corp-purchases-7549-shares-of-petmed-express-inc-pets.html.
A number of equities research analysts recently issued reports on PETS shares. ValuEngine raised shares of PetMed Express from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Sidoti raised shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 price target on the stock in a research note on Thursday, August 24th. BidaskClub downgraded shares of PetMed Express from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 22nd. Northcoast Research raised shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price target on the stock in a research note on Monday, July 24th. Finally, Zacks Investment Research downgraded shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $42.00.
Shares of PetMed Express, Inc. (PETS) opened at $37.39 on Tuesday. PetMed Express, Inc. has a 12 month low of $19.21 and a 12 month high of $50.90. The firm has a market cap of $768.34, a price-to-earnings ratio of 25.03, a PEG ratio of 2.25 and a beta of 1.09.
PetMed Express (NASDAQ:PETS) last announced its earnings results on Monday, October 23rd. The company reported $0.43 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.30 by $0.13. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The business had revenue of $66.70 million for the quarter, compared to the consensus estimate of $63.41 million. During the same quarter in the prior year, the firm posted $0.24 earnings per share. The business’s revenue for the quarter was up 9.7% on a year-over-year basis. analysts anticipate that PetMed Express, Inc. will post 1.66 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 17th. Investors of record on Monday, November 6th will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.14%. The ex-dividend date is Friday, November 3rd. PetMed Express’s dividend payout ratio is presently 53.69%.
In related news, Director Ronald J. Korn sold 1,000 shares of the firm’s stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $35.57, for a total value of $35,570.00. Following the transaction, the director now owns 73,833 shares of the company’s stock, valued at approximately $2,626,239.81. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 4.00% of the company’s stock.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.